Factory
Develops an autonomous software-development platform for enterprise engineering teams.
$200MFunding
Role not disclosedNE
New Enterprise Associates (NEA)
Activity from announced rounds
Activity in this selectionOct 17, 2026 · Jul 20, 2026
New Enterprise Associates invests in technology and healthcare companies from incubation and seed through growth, with expertise spanning software, digital health and life sciences.
NEA operates dedicated early-stage and venture growth funds within its broader company-building strategy. Its healthcare mandate includes scientific development as well as digital products, while technology investing covers enterprise and consumer businesses.
This structure lets it engage with a team forming a company or with an established business financing expansion. The appropriate partner depends on both the development stage and whether the central challenge is technical, clinical or commercial.
- Rounds participated in
- 6
- Confirmed lead rounds
- 1 5 roles undisclosed
- New companies
- 6 First participation on record · 0 follow-on
- Funding in participating rounds
- $985M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
6 in this selectionPositron AI
Positron AI develops memory-focused hardware and software for large-language-model inference.
≤$875MSeries C and Series C-1 financing package
LeadAbcuro
Clinical-stage immunotherapies targeting pathogenic cytotoxic T cells in autoimmune disease.
$66MSeries D
Role not disclosedHorizon3
Runs autonomous AI-driven penetration testing to secure enterprise networks
$250MSeries E
Role not disclosedCentralize
Relationship intelligence platform for enterprise revenue teams
$19MSeed+
Role not disclosedCuspAI
Developing AI systems to discover and design new materials for clean energy and chipmaking
$450MSeries B
Role not disclosed